BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2989977)

  • 1. Effect of the thromboxane receptor antagonist EP 092 on endotoxin shock in the sheep.
    Armstrong RA; Jones RL; Wilson NH
    Prostaglandins; 1985 May; 29(5):703-13. PubMed ID: 2989977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
    Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action and metabolism of prostaglandins in the pulmonary circulation.
    Kadowitz PJ; Lippton HL; McNamara DB; Spannhake EW; Hyman AL
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():333-56. PubMed ID: 6216787
    [No Abstract]   [Full Text] [Related]  

  • 5. Endotoxin priming of thromboxane-related vasoconstrictor responses in perfused rabbit lungs.
    Steudel W; Krämer HJ; Degner D; Rosseau S; Schütte H; Walmrath D; Seeger W
    J Appl Physiol (1985); 1997 Jul; 83(1):18-24. PubMed ID: 9216939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-dependent and independent responses to prostaglandin H2 and arachidonic acid in isolated dog cerebral arteries.
    Toda N; Inoue S; Bian K; Okamura T
    J Pharmacol Exp Ther; 1988 Jan; 244(1):297-302. PubMed ID: 3121847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene antagonist FPL 57231 prevents the acute pulmonary effects of Escherichia coli endotoxin in cats.
    Pacitti N; Bryson SE; McKechnie K; Rodger IW; Parratt JR
    Circ Shock; 1987; 21(2):155-68. PubMed ID: 3549040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of thromboxane receptors in human platelets.
    Jones RL; Wilson NH; Armstrong RA
    Adv Exp Med Biol; 1985; 192():67-81. PubMed ID: 3010674
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of verapamil on the pulmonary vasoconstrictor action of prostaglandin F2 alpha and a synthetic PGH2 analogue.
    Angerio AD; Fitzpatrick TM; Kot PA; Ramwell PW; Rose JC
    Br J Pharmacol; 1981 May; 73(1):101-3. PubMed ID: 7284690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin B2-induced pulmonary hypertension is mediated by TxA2/PGH2 receptor stimulation.
    Liu F; Orr JA; Wu JY
    Am J Physiol; 1994 Nov; 267(5 Pt 1):L602-8. PubMed ID: 7977770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand binding to thromboxane receptors on human platelets: correlation with biological activity.
    Armstrong RA; Jones RL; Wilson NH
    Br J Pharmacol; 1983 Aug; 79(4):953-64. PubMed ID: 6317122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of responses to leukotriene D4 in the pulmonary vascular bed.
    Kadowitz PJ; Hyman AL
    Circ Res; 1984 Nov; 55(5):707-17. PubMed ID: 6435907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
    Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
    Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of verapamil on pulmonary and eicosanoid responses to endotoxin in awake sheep.
    Ahmed T; D'Brot J; Wasserman M; Muccitelli R; Robinson M; Tucker S; Marchette B
    J Appl Physiol (1985); 1988 Apr; 64(4):1700-8. PubMed ID: 3163996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
    Parise LV; Venton DL; Le Breton GC
    J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA; Heran CL; Ogletree ML
    Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effects of a pyridoquinazoline thromboxane synthetase inhibitor on arachidonic acid metabolites and hemodynamics during E. coli endotoxemia in anesthetized sheep.
    Morel DR; Huttemeier PC; Skoskiewicz MJ; Nguyenduy T; Melvin C; Robinson DR; Zapol WM
    Prostaglandins; 1987 Jun; 33(6):879-902. PubMed ID: 3118413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581. A novel inhibitor of thromboxane synthesis.
    Kadowitz PJ; Nandiwada PA; Spannhake EW; Rosenson RS; McNamara DB; Hyman AL
    Chest; 1983 May; 83(5 Suppl):72S-74S. PubMed ID: 6404609
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
    Rump LC; Schollmeyer P
    Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.